Guardant Health Receives FDA Approval for Guardant360 CDx Companion Diagnostic

SentiSense · Published · Updated

Guardant Health received FDA approval for Guardant360 CDx as a companion diagnostic for Boehringer Ingelheim's HERNEXEOS. This marks a significant mil...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis